CP
ABBV icon

Creekside Partners’s AbbVie ABBV Stock Holding History

Creekside Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Hold
1,930
– – 0.18% 114
2026
Q1 		$420K Sell
1,930
-27
-1% -$5.99K 0.17% 115
2025
Q4 		$447K Hold
1,957
– – 0.19% 110
2025
Q3 		$453K Hold
1,957
– – 0.2% 108
2025
Q2 		$363K Hold
1,957
– – 0.17% 123
2025
Q1 		$410K Hold
1,957
– – 0.21% 103
2024
Q4 		$348K Hold
1,957
– – 0.18% 123
2024
Q3 		$386K Hold
1,957
– – 0.2% 116
2024
Q2 		$336K Buy
+1,957
New +$324K 0.19% 123

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Creekside Partners's ABBV Position: Q2 2026 in Review

Creekside Partners held its AbbVie (ABBV) position steady in Q2 2026 at 1,930 shares worth $486K. The position accounts for 0.18% of the portfolio, ranked #114.

Creekside Partners first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Creekside Partners held 1,930 shares of AbbVie worth $486K as of Q2 2026.
  • Creekside Partners left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.18% of Creekside Partners's portfolio in Q2 2026, its #114 holding.
  • Creekside Partners first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Creekside Partners's 13F filing for Q2 2026, filed 31 Jul 2026.